Safety and efficacy of a genetic vaccine targeting Telomerase plus chemotherapy for the therapy of canine B-cell lymphoma

20132 citationsJournal Articlegold Open Access

Authors

Alessandra Gavazza · University of Pisa

George Lubas · University of Pisa

Arthur Fridman · Merck (Japan)

Daniela Peruzzi · Sapienza University of Rome

Joseph A. Impellizeri · vTv Therapeutics (United States)

Laura Luberto

Emanuele Marra

Giuseppe Roscilli

Abstract

Meeting abstracts Client-owned pet dogs represent exceptional translational models for advancement of Cancer Research, as they reflects the complex heterogeneity observed in human cancer. We have recently shown that a genetic vaccine targeting dog telomerase (dTERT) and based on Ad/DNA-EGT

Topics & Keywords

Virus-based gene therapy research Cancer Research and Treatments Immunotherapy and Immune Responses

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal for ImmunoTherapy of Cancer

Volume 1, Issue Suppl 1, pp. P212-P212

DOI: 10.1186/2051-1426-1-s1-p212

Field-Weighted Citation Impact: 0.00